# Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants

> **NCT07629999** · PHASE1 · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 136 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986533
- **DRUG:** Famotidine
- **DRUG:** Placebo
- **DRUG:** Dabigatran Etexilate
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT07629999
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629999, "Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*